Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.6468
-0.1332 (-17.08%)
At close: Mar 23, 2026, 4:00 PM EDT
0.6070
-0.0398 (-6.15%)
Pre-market: Mar 24, 2026, 7:16 AM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $69.74 million as of March 24, 2026. Its market cap has increased by 551.84% in one year.
Market Cap
69.74M
Enterprise Value
69.74M
1-Year Change
551.84%
Ranking
Category
Stock Price
$0.65
Market Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $69.74M, an increase of 102.18%. That is a compound annual growth rate of 59.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 69.74M | 32.00% |
| Dec 31, 2025 | 52.83M | 216.73% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 88.85M |
| Aardvark Therapeutics | 88.62M |
| Cingulate | 85.82M |
| NeurAxis | 85.25M |
| Vivani Medical | 84.62M |
| Kazia Therapeutics | 81.50M |
| Seres Therapeutics | 81.48M |
| Champions Oncology | 81.38M |